Predictive Oncology Inc.
POAI
$0.95
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.24% | -12.60% | -- | -- | 24.59% |
| Total Depreciation and Amortization | 2.53% | -71.04% | -- | -- | 1.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -241.47% | 2,864.29% | -- | -- | 869.62% |
| Change in Net Operating Assets | -177.29% | 310.49% | -- | -- | -184.31% |
| Cash from Operations | -339.48% | 64.80% | -- | -- | 5.79% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -- | -116.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 66.19% |
| Issuance of Common Stock | -77.28% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -54.45% | -- | -- | -- | -- |
| Cash from Financing | -70.92% | 1,376.66% | -- | -- | 3,088.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -209.65% | 201.02% | -- | -- | 103.81% |